Manejo médico de pacientes con hemofilia A,B y enfermedad de Von Willebrand llevados a cirugía al Hospital San José, Bogotá: 16 años de experiencia

Autores:
Peña Castellanos, Ángela María
Solano Trujillo, María Helena
Villamizar Gómez, Francy Licet
Tipo de recurso:
Article of journal
Fecha de publicación:
2011
Institución:
Fundación Universitaria de Ciencias de la Salud - FUCS
Repositorio:
Repositorio Digital Institucional ReDi
Idioma:
spa
OAI Identifier:
oai:repositorio.fucsalud.edu.co:001/2802
Acceso en línea:
https://repositorio.fucsalud.edu.co/handle/001/2802
https://doi.org/10.31260/RepertMedCir.v20.n4.2011.779
Palabra clave:
hemofilia
enfermedad de von Willebrand
cirugía
hemophilia
von Willebrand disease
surgery
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-sa/4.0/
id FUCS2_894452f7cc17415cbf9835317460c5f6
oai_identifier_str oai:repositorio.fucsalud.edu.co:001/2802
network_acronym_str FUCS2
network_name_str Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv Manejo médico de pacientes con hemofilia A,B y enfermedad de Von Willebrand llevados a cirugía al Hospital San José, Bogotá: 16 años de experiencia
dc.title.translated.eng.fl_str_mv Medical management of patients with hemophilia A, B and Von Willebrand disease who underwent surgery a sixteen year experience at Hospital de San José, Bogotá
title Manejo médico de pacientes con hemofilia A,B y enfermedad de Von Willebrand llevados a cirugía al Hospital San José, Bogotá: 16 años de experiencia
spellingShingle Manejo médico de pacientes con hemofilia A,B y enfermedad de Von Willebrand llevados a cirugía al Hospital San José, Bogotá: 16 años de experiencia
hemofilia
enfermedad de von Willebrand
cirugía
hemophilia
von Willebrand disease
surgery
title_short Manejo médico de pacientes con hemofilia A,B y enfermedad de Von Willebrand llevados a cirugía al Hospital San José, Bogotá: 16 años de experiencia
title_full Manejo médico de pacientes con hemofilia A,B y enfermedad de Von Willebrand llevados a cirugía al Hospital San José, Bogotá: 16 años de experiencia
title_fullStr Manejo médico de pacientes con hemofilia A,B y enfermedad de Von Willebrand llevados a cirugía al Hospital San José, Bogotá: 16 años de experiencia
title_full_unstemmed Manejo médico de pacientes con hemofilia A,B y enfermedad de Von Willebrand llevados a cirugía al Hospital San José, Bogotá: 16 años de experiencia
title_sort Manejo médico de pacientes con hemofilia A,B y enfermedad de Von Willebrand llevados a cirugía al Hospital San José, Bogotá: 16 años de experiencia
dc.creator.fl_str_mv Peña Castellanos, Ángela María
Solano Trujillo, María Helena
Villamizar Gómez, Francy Licet
dc.contributor.author.spa.fl_str_mv Peña Castellanos, Ángela María
Solano Trujillo, María Helena
dc.contributor.author.none.fl_str_mv Villamizar Gómez, Francy Licet
dc.subject.spa.fl_str_mv hemofilia
enfermedad de von Willebrand
cirugía
topic hemofilia
enfermedad de von Willebrand
cirugía
hemophilia
von Willebrand disease
surgery
dc.subject.eng.fl_str_mv hemophilia
von Willebrand disease
surgery
publishDate 2011
dc.date.accessioned.none.fl_str_mv 2011-12-01 00:00:00
2022-06-29T19:36:39Z
dc.date.issued.none.fl_str_mv 2011-12-01
dc.date.available.none.fl_str_mv 2011-12-01 00:00:00
2022-06-29T19:36:39Z
dc.type.spa.fl_str_mv Artículo de revista
dc.type.eng.fl_str_mv Journal article
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv Text
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.31260/RepertMedCir.v20.n4.2011.779
dc.identifier.issn.none.fl_str_mv 0121-7372
dc.identifier.uri.none.fl_str_mv https://repositorio.fucsalud.edu.co/handle/001/2802
dc.identifier.eissn.none.fl_str_mv 2462-991X
dc.identifier.url.none.fl_str_mv https://doi.org/10.31260/RepertMedCir.v20.n4.2011.779
identifier_str_mv 10.31260/RepertMedCir.v20.n4.2011.779
0121-7372
2462-991X
url https://repositorio.fucsalud.edu.co/handle/001/2802
https://doi.org/10.31260/RepertMedCir.v20.n4.2011.779
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Sans-Sabrafen J, Besses-Raebel C, Vives-Corrons J. Coagulopatías plasmáticas congénitas. In: Elsevier, editor. Hematología clínica. 5a. edición Madrid. 2006;725-44. 2. Lichtman M, Beutler E, J(jpps T. Seligsohn U, Kaushanshy K,Prchal J. Williams Hematology. 7a. edición. 2006. 3. Mariani G, Konk.le B, lngerslev J. Congenital factor VIl deficiency: therapy with recombinan! activated factor Vll-a critica! appraisal. Hemophi!ia. 2006;12:19-27. 4. Lapecorella M,Mariani G. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options. Haemophilia 2008; 1 4:1170-5. 5. lngerslev J, Hvad J. Surgery in Hemophilia. The general view: Patient selection, liming and preoperative assessment. Semin Hematol. 2006;43(Suppl 1):23-6. 6. Rickard K. Guidelines for therapy and optima! dosages of coagulation factors for treatment of bleeding and surgery in haemophilia. Haemophilia. 1995;1(Suppl. 1):8-13. 7. FederaciónMundial de Hemofilia. Directrices para el tratamiento de la hemofilia. 2005. 8. Comisión latinoamericana sobre la terapéutica de personas con inhibidores CLOTTING. 2010. 9. World Federation of Hemophilia Global Survey. Annual global survey. 2009. 10. Mathews V, ViswabandyaA, Baidya S,George B,NairS,ChandyM,eta!. Surgery for hemophilia in developing countries. Semin Thromb Hemost. 2005;31(5):538-43. 11. Plug J, Van Der Bom G, Peter M, Mauser-Bunschoten EP, De Goede A, Bolder L, et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost. 2006;4(3):510-6. 12. Yee T, Lee C. Transfusion-transmitted infection in hemophilia in developing countries. Seminars in thrombosis and hemostasis.2005;31(5):527-37. 13. Bolton-Maggs P. Optima! haemophilia care versus reality. British Journal of Hematology. 2005;132:671-82. 14. Astermark J. Why do inhibitors develop? Principies of and factors influencing the risk for inhibitor development in haemophilia. Haemophilia. 2006;(12):52-60. 15. Bemtorp E. Options for treating acote bleeds in addition to bypassing agents: extracorporealimmunoadsorption, FVIII/FIX, desmopressinandantifibrinolytics. Haemophilia. 2006;12(Suppl 6):62-6. 16. Kraut EH, Aledort LM, Arkin S, Stine KC, Wong WY. SurgicaJ interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review. Haemophilia. 2007;13:508-17. 17. Giangrande PL, Wilde JT, Madan B, Ludlam CA, Tuddenham EG, Goddard NJ, et al. Consensos protocol for lhe use of recombinantactivatedfactor VII (eptacog alta (activated); NovoSeven) in elective orthopaedic surgery in haemophilic patients with inhibitors. Haemophilia. 2009;15:501-8. 18. Marrnuci P. How I treal age-related morbidilies in elderly persons with hemophilia. Blood. 2009;114:5256-63. 19. Hermans C, Altisent C, Batorova A, Chambos! H, De Moerloose P, Karafoulidou A, et al. Replacement therapy for invasive procedures in patients with haemophilia: literature review, European Surveyand recommendations. Haemophilia. 2009;15:639- 58. 20. Franchini M, Rossetti G, Tagliaferri A, Pattacini C, Pozzoli D, Lorenz C, et al. Dental procedures in adult patients with hereditary bleeding disorders: JO years experience in lhree Italian Hemophilia Centers. Haemophilia. 2005 Sep;11(5):504-9. 21. Gómez JF, Duarte M, Raffansanabria F. Radical prostatectomy in hemophiliac patienl. Arch Esp Uro!. 2003 Sep;56(7):827-9. 22. Giangrande P, Wilde J. Consensos protocol for the use of recombinan! activated factor Vlla in elective orthopaedic surgery in haemophilic patients with inhibitors. Hemophilia. 2009;15:501-8. 23. Rodeghiero F, Castaman G, Tosetto A. How I treat von Willebrand disease. Blood. 2009;114(6):1158-65. 24. Schulman S, Loogna J, Wallensten R. Minimizing factor requirements for surgery wilhout increased risk. Haemophilia. 2004 Oct;I0(Suppl 4):35-40. 25. Srivastava A, You S, Ayob Y, Chuansumrit A, De Bosch N, Pérez-Bianco R, et al. Hemophilia treatment in developing countries: products and protocols. Seminars in thrombosis and hemostasis. 2005;31(495):537.
dc.relation.bitstream.none.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/779/816
dc.relation.citationedition.spa.fl_str_mv Núm. 4 , Año 2011 : Octubre – Diciembre
dc.relation.citationendpage.none.fl_str_mv 239
dc.relation.citationissue.spa.fl_str_mv 4
dc.relation.citationstartpage.none.fl_str_mv 233
dc.relation.citationvolume.spa.fl_str_mv 20
dc.relation.ispartofjournal.spa.fl_str_mv Revista Repertorio de Medicina y Cirugía
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/779
institution Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv https://repositorio.fucsalud.edu.co/bitstreams/181b117c-58bc-44bf-b293-54601e17d15a/download
bitstream.checksum.fl_str_mv 8e4c6f86fc83eeeaf62381a5904cd904
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv redi@fucsalud.edu.co
_version_ 1811575321128861696
spelling Peña Castellanos, Ángela María5522323b3b5323c4eea78e7052e97f74300Solano Trujillo, María Helena6d28e8fac6cfb21717498464f06679b6Villamizar Gómez, Francy Licetvirtual::44-12011-12-01 00:00:002022-06-29T19:36:39Z2011-12-012011-12-01 00:00:002022-06-29T19:36:39ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Saludhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/779hemofiliaenfermedad de von Willebrandcirugíahemophiliavon Willebrand diseasesurgeryManejo médico de pacientes con hemofilia A,B y enfermedad de Von Willebrand llevados a cirugía al Hospital San José, Bogotá: 16 años de experienciaMedical management of patients with hemophilia A, B and Von Willebrand disease who underwent surgery a sixteen year experience at Hospital de San José, Bogotáapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v20.n4.2011.7790121-7372https://repositorio.fucsalud.edu.co/handle/001/28022462-991Xhttps://doi.org/10.31260/RepertMedCir.v20.n4.2011.779spaSans-Sabrafen J, Besses-Raebel C, Vives-Corrons J. Coagulopatías plasmáticas congénitas. In: Elsevier, editor. Hematología clínica. 5a. edición Madrid. 2006;725-44. 2. Lichtman M, Beutler E, J(jpps T. Seligsohn U, Kaushanshy K,Prchal J. Williams Hematology. 7a. edición. 2006. 3. Mariani G, Konk.le B, lngerslev J. Congenital factor VIl deficiency: therapy with recombinan! activated factor Vll-a critica! appraisal. Hemophi!ia. 2006;12:19-27. 4. Lapecorella M,Mariani G. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options. Haemophilia 2008; 1 4:1170-5. 5. lngerslev J, Hvad J. Surgery in Hemophilia. The general view: Patient selection, liming and preoperative assessment. Semin Hematol. 2006;43(Suppl 1):23-6. 6. Rickard K. Guidelines for therapy and optima! dosages of coagulation factors for treatment of bleeding and surgery in haemophilia. Haemophilia. 1995;1(Suppl. 1):8-13. 7. FederaciónMundial de Hemofilia. Directrices para el tratamiento de la hemofilia. 2005. 8. Comisión latinoamericana sobre la terapéutica de personas con inhibidores CLOTTING. 2010. 9. World Federation of Hemophilia Global Survey. Annual global survey. 2009. 10. Mathews V, ViswabandyaA, Baidya S,George B,NairS,ChandyM,eta!. Surgery for hemophilia in developing countries. Semin Thromb Hemost. 2005;31(5):538-43. 11. Plug J, Van Der Bom G, Peter M, Mauser-Bunschoten EP, De Goede A, Bolder L, et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost. 2006;4(3):510-6. 12. Yee T, Lee C. Transfusion-transmitted infection in hemophilia in developing countries. Seminars in thrombosis and hemostasis.2005;31(5):527-37. 13. Bolton-Maggs P. Optima! haemophilia care versus reality. British Journal of Hematology. 2005;132:671-82. 14. Astermark J. Why do inhibitors develop? Principies of and factors influencing the risk for inhibitor development in haemophilia. Haemophilia. 2006;(12):52-60. 15. Bemtorp E. Options for treating acote bleeds in addition to bypassing agents: extracorporealimmunoadsorption, FVIII/FIX, desmopressinandantifibrinolytics. Haemophilia. 2006;12(Suppl 6):62-6. 16. Kraut EH, Aledort LM, Arkin S, Stine KC, Wong WY. SurgicaJ interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review. Haemophilia. 2007;13:508-17. 17. Giangrande PL, Wilde JT, Madan B, Ludlam CA, Tuddenham EG, Goddard NJ, et al. Consensos protocol for lhe use of recombinantactivatedfactor VII (eptacog alta (activated); NovoSeven) in elective orthopaedic surgery in haemophilic patients with inhibitors. Haemophilia. 2009;15:501-8. 18. Marrnuci P. How I treal age-related morbidilies in elderly persons with hemophilia. Blood. 2009;114:5256-63. 19. Hermans C, Altisent C, Batorova A, Chambos! H, De Moerloose P, Karafoulidou A, et al. Replacement therapy for invasive procedures in patients with haemophilia: literature review, European Surveyand recommendations. Haemophilia. 2009;15:639- 58. 20. Franchini M, Rossetti G, Tagliaferri A, Pattacini C, Pozzoli D, Lorenz C, et al. Dental procedures in adult patients with hereditary bleeding disorders: JO years experience in lhree Italian Hemophilia Centers. Haemophilia. 2005 Sep;11(5):504-9. 21. Gómez JF, Duarte M, Raffansanabria F. Radical prostatectomy in hemophiliac patienl. Arch Esp Uro!. 2003 Sep;56(7):827-9. 22. Giangrande P, Wilde J. Consensos protocol for the use of recombinan! activated factor Vlla in elective orthopaedic surgery in haemophilic patients with inhibitors. Hemophilia. 2009;15:501-8. 23. Rodeghiero F, Castaman G, Tosetto A. How I treat von Willebrand disease. Blood. 2009;114(6):1158-65. 24. Schulman S, Loogna J, Wallensten R. Minimizing factor requirements for surgery wilhout increased risk. Haemophilia. 2004 Oct;I0(Suppl 4):35-40. 25. Srivastava A, You S, Ayob Y, Chuansumrit A, De Bosch N, Pérez-Bianco R, et al. Hemophilia treatment in developing countries: products and protocols. Seminars in thrombosis and hemostasis. 2005;31(495):537.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/779/816Núm. 4 , Año 2011 : Octubre – Diciembre239423320Revista Repertorio de Medicina y Cirugíainfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2Publication89867781-8b73-4edb-adc3-85bacc6d7d3dvirtual::44-189867781-8b73-4edb-adc3-85bacc6d7d3dvirtual::44-10000-0002-1875-114Xvirtual::44-1https://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0000498319virtual::44-1OREORE.xmltext/xml3109https://repositorio.fucsalud.edu.co/bitstreams/181b117c-58bc-44bf-b293-54601e17d15a/download8e4c6f86fc83eeeaf62381a5904cd904MD51001/2802oai:repositorio.fucsalud.edu.co:001/28022024-06-14 11:03:27.217https://creativecommons.org/licenses/by-nc-sa/4.0/metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Publicaciones similares